IGHE and asthma: As stated by the authors of the study, this evidence might not only be indicative of the physiological complexity of AHR, but it might also suggest that IgE and eosinophils, which were significantly decreased with omalizumab, may not mediate methacholine responsiveness in mild to moderate asthma [36].